Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer

By Patel Sharmila   Player Mark R  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1865-1882

Informa Healthcare

Access to resources Recommend Favorite

Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists

By  

Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. : 560-568

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Inhibitors of p53-MDM2 Interaction: the 2006-2010 Update

By  

Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-01 ,pp. : 536-559

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors

By Sawyer Tomi K  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Novel Mitotic Targets and Their Small-Molecule Inhibitors

By  

Current Cancer Drug Targets, Vol. 7, Iss. 8, 2007-12 ,pp. : 766-784

Bentham Science Publishers

Access to resources Recommend Favorite